132 related articles for article (PubMed ID: 36154884)
1. Non-Invasive Diagnostics of Renal Cell Carcinoma Using Ultrasensitive Immunodetection of Cancer-Retina Antigens.
Shlyapnikov YM; Malakhova EA; Potoldykova NV; Svetocheva YA; Vinarov AZ; Zinchenko DV; Zernii EY; Zamyatnin AA; Shlyapnikova EA
Biochemistry (Mosc); 2022 Jul; 87(7):658-666. PubMed ID: 36154884
[TBL] [Abstract][Full Text] [Related]
2. [Aberrant expression of arrestin-1 and recoverin in kidney tumors].
Tsoy LV; Korolev DO; Vinarov AZ; Enikeev ME; Lerner YV; Tsarichenko DG; Popov NA; Abdusalamov AF; Gorobets YP; Demidko YL; Varshavskiy VA; Zamyatnin AA; Rapoport LM
Urologiia; 2019 Dec; (6):48-53. PubMed ID: 32003167
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Retina Antigens in the Urine of Bladder and Prostate Cancer Patients.
Shlyapnikov YM; Malakhova EA; Vinarov AZ; Potoldykova NV; Vladimirov VI; Zernii EY; Zamyatnin AA; Shlyapnikova EA
Biochemistry (Mosc); 2022 Nov; 87(11):1268-1276. PubMed ID: 36509724
[TBL] [Abstract][Full Text] [Related]
4. The cancer-retina antigen recoverin as a potential biomarker for renal tumors.
Golovastova MO; Tsoy LV; Bocharnikova AV; Korolev DO; Gancharova OS; Alekseeva EA; Kuznetsova EB; Savvateeva LV; Skorikova EE; Strelnikov VV; Varshavsky VA; Vinarov AZ; Nikolenko VN; Glybochko PV; Zernii EY; Zamyatnin AA; Bazhin AV; Philippov PP
Tumour Biol; 2016 Jul; 37(7):9899-907. PubMed ID: 26813565
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
[TBL] [Abstract][Full Text] [Related]
6. Recoverin as a cancer-retina antigen.
Bazhin AV; Schadendorf D; Philippov PP; Eichmüller SB
Cancer Immunol Immunother; 2007 Jan; 56(1):110-6. PubMed ID: 16444517
[TBL] [Abstract][Full Text] [Related]
7. Cancer-retina antigens -- a new group of tumor antigens.
Golovastova MO; Bazhin AV; Philippov PP
Biochemistry (Mosc); 2014 Aug; 79(8):733-9. PubMed ID: 25365483
[TBL] [Abstract][Full Text] [Related]
8. Early detection of kidney cancer using urinary proteins: a truly non-invasive strategy.
Flitcroft JG; Verheyen J; Vemulkar T; Welbourne EN; Rossi SH; Welsh SJ; Cowburn RP; Stewart GD
BJU Int; 2022 Mar; 129(3):290-303. PubMed ID: 34570419
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
10. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
[TBL] [Abstract][Full Text] [Related]
11. Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes.
Kim YH; Kim YS; Noh HS; Kang SS; Cheon EW; Park SK; Lee BJ; Choi WS; Cho GJ
Exp Eye Res; 2005 Jun; 80(6):753-60. PubMed ID: 15939031
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
13. Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study.
Oto J; Fernández-Pardo Á; Roca M; Plana E; Solmoirago MJ; Sánchez-González JV; Vera-Donoso CD; Martínez-Sarmiento M; España F; Navarro S; Medina P
J Proteomics; 2020 Apr; 218():103723. PubMed ID: 32126320
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic liquid biopsy biomarkers in renal cell cancer.
Zieren RC; Zondervan PJ; Pienta KJ; Bex A; de Reijke TM; Bins AD
Nat Rev Urol; 2024 Mar; 21(3):133-157. PubMed ID: 37758847
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against arrestin-1 as a potential biomarker of renal cell carcinoma.
Baldin AV; Grishina AN; Korolev DO; Kuznetsova EB; Golovastova MO; Kalpinskiy AS; Alekseev BY; Kaprin AD; Zinchenko DV; Savvateeva LV; Varshavsky VA; Zernii EY; Vinarov AZ; Bazhin AV; Philippov PP; Zamyatnin AA
Biochimie; 2019 Feb; 157():26-37. PubMed ID: 30389514
[TBL] [Abstract][Full Text] [Related]
16. Molecular evidence that human ocular ciliary epithelium expresses components involved in phototransduction.
Bertazolli-Filho R; Ghosh S; Huang W; Wollmann G; Coca-Prados M
Biochem Biophys Res Commun; 2001 Jun; 284(2):317-25. PubMed ID: 11394879
[TBL] [Abstract][Full Text] [Related]
17. Urinary NMP22 and renal cell carcinoma.
Huang S; Rhee E; Patel H; Park E; Kaswick J
Urology; 2000 Feb; 55(2):227-30. PubMed ID: 10688084
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of cellular fibronectin in patients with localized and metastatic renal cell carcinoma.
Hegele A; Heidenreich A; Kropf J; von Knobloch R; Varga Z; Hofmann R; Olbert P
Tumour Biol; 2004; 25(3):111-6. PubMed ID: 15361707
[TBL] [Abstract][Full Text] [Related]
19. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for the Detection and Surveillance of Renal Cancer.
Nolazco JI; Soerensen SJC; Chung BI
Urol Clin North Am; 2023 May; 50(2):191-204. PubMed ID: 36948666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
